Psychedelics, Hallucinogens and Entheogens: What Clinicians Need to Know
Psychedelics, Hallucinogens, and Entheogens equips mental health practitioners with crucial insights on addressing psychedelic usage in therapeutic settings
- 50 Enrolled
- Last updated Aug '23
Psychedelics, Hallucinogens and Entheogens: What Clinicians Need to Know provides mental health professionals essential knowledge for addressing psychedelic use in clinical contexts. Taught by psychedelic researcher and clinician Dr. Peter Addy, this course bridges the gaps between prohibitive misconceptions, emerging science, and clients’ real-world psychedelic experiences.
Through online modules, participants gain updated understandings of classic and atypical psychedelics, traditional uses, current research, therapeutic mechanisms, integration models, ethical dilemmas, and clinical applications. Clinicians develop skills for competently navigating discussions of psychedelics in therapy, determining risks and benefits, and leveraging psychedelics’ potential to catalyze healing from trauma, addiction, mood disorders, and more.
This course equips clinicians to meet the needs of an increasingly psychedelic society.
Tatayo (“Fruit of the Wind”) first arrived in Gabon in 1971 at the age of 21 and became a Gabonese citizen. In 1979, he became the first white person to be initiated into the Bwiti Fang tradition in Gabon. In 1994, he was initiated into the Misokko tradition. As a guide for numerous expeditions and missions, including those of National Geographic, the BBC, and others, Tatayo is considered to have “opened the door” to westerners in Gabon.